Market research
0P0.F Aerie Pharmaceuticals, Inc
F EUR Not available
Latest close
16.934
—
As of 29 Oct 2026
Test a moving-average rule with historical data.
Market facts
- Market cap
- 8B
- P/E ratio
- Not available
- Analyst target
- Not available
- Dividend yield
- Not available
- Beta
- Not available
Community
Investor discussion
1 comment
Sign in to join the 0P0.F discussion.
5 years, 6 months ago
Aerie Pharmaceuticals, Inc is currently in a long term downtrend where the price is trading 0.6% below its 200 day moving average.
From a valuation standpoint, the stock is 99.2% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 9.9.
Aerie Pharmaceuticals, Inc's total revenue rose by 0.1% to $25M since the same quarter in the previous year.
Its net income has increased by 16.2% to $-46M since the same quarter in the previous year.
Finally, its free cash flow grew by 174.6% to $22M since the same quarter in the previous year.
Based on the above factors, Aerie Pharmaceuticals, Inc gets an overall score of 4/5.